title: Pannexin1 contributes to pathophysiological ATP release in lipoapoptosis induced by saturated free fatty acids in liver cells.
abstract: Hepatocyte lipoapoptosis induced by saturated free fatty acids (FFA) contributes to hepatic inflammation in lipotoxic liver injury, and the cellular mechanisms involved have not been defined. Recent studies have shown that apoptosis in nonhepatic cells stimulates ATP release via activation of pannexin1 (panx1), and extracellular ATP functions as a proinflammatory signal for recruitment and activation of the inflammatory cells. However, it is not known whether lipoapoptosis stimulates ATP release in liver cells. We found that lipoapoptosis induced by saturated FFA stimulated ATP release in liver cells that increased extracellular ATP concentration by more than fivefold above the values observed in healthy cells. This sustained pathophysiological ATP release was not dependent on caspase-3/7 activation. Inhibition of c-Jun NH(2)-terminal kinase (JNK), a key mediator of lipoapoptosis, with SP600125 blocked pathophysiological ATP release in a dose-dependent manner. RT-PCR analysis indicated that panx1 is expressed in hepatocytes and multiple liver cell lines. Notably, inhibition of panx1 expression with short hairpin (sh)RNA inhibited in part pathophysiological ATP release. Moreover, lipoapoptosis stimulated uptake of a membrane impermeable dye YoPro-1 (indicative of panx1 activation), which was inhibited by panx1 shRNA, probenecid, and mefloquine. These results suggest that panx1 contributes to pathophysiological ATP release in lipoapoptosis induced by saturated FFA. Thus panx1 may play an important role in hepatic inflammation by mediating an increase in extracellular ATP concentration in lipotoxic liver injury.
authors.affiliation: Deptartment of Internal Medicine, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75390-9151, USA.
authors.forename: Feng
authors.initials: F
authors.lastname: Xiao
authors.forename: Shar L
authors.initials: SL
authors.lastname: Waldrop
authors.forename: Al-karim
authors.initials: AK
authors.lastname: Khimji
authors.forename: Gordan
authors.initials: G
authors.lastname: Kilic
mesh_terms: D000255:Adenosine Triphosphate / Q000378:metabolism*; D000818:Animals; D017209:Apoptosis / Q000502:physiology*; D001583:Benzoxazoles / Q000378:metabolism; D045744:Cell Line, Tumor; D049109:Cell Proliferation; D048429:Cell Size; D002470:Cell Survival; D004396:Coloring Agents / Q000378:metabolism; D017630:Connexins / Q000235:genetics / Q000378:metabolism*; D005227:Fatty Acids / Q000494:pharmacology*; D005786:Gene Expression Regulation / Q000502:physiology; D022781:Hepatocytes / Q000187:drug effects / Q000378:metabolism* / Q000473:pathology; D006801:Humans; D019169:Jurkat Cells; D009419:Nerve Tissue Proteins / Q000235:genetics / Q000378:metabolism*; D011804:Quinolines / Q000378:metabolism; D011806:Quinolinium Compounds; D034741:RNA, Small Interfering; D051381:Rats; D060888:Real-Time Polymerase Chain Reaction; D020133:Reverse Transcriptase Polymerase Chain Reaction
chemical_list: D001583:Benzoxazoles; D004396:Coloring Agents; D017630:Connexins; D005227:Fatty Acids; D009419:Nerve Tissue Proteins; C492764:PANX1 protein, human; D011804:Quinolines; D011806:Quinolinium Compounds; D034741:RNA, Small Interfering; C479936:pannexin 1, rat; C089813:YO-PRO 1; D000255:Adenosine Triphosphate